FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

448800004: Eribulin mesilate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2011. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2901391010 Eribulin mesylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726091011 Eribulin mesilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726092016 Eribulin mesilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
809341000172119 mésilate d'éribuline fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eribulin mesilate (substance) Is a Microtubule inhibitor true Inferred relationship Some
Eribulin mesilate (substance) Is a Ketone true Inferred relationship Some
Eribulin mesilate (substance) Is a Eribulin (substance) false Inferred relationship Some
Eribulin mesilate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Microtubule inhibitor (disposition) true Inferred relationship Some
Eribulin mesilate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Eribulin (substance) true Inferred relationship Some
Eribulin mesilate (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Eribulin mesylate 0.5mg/mL solution for intravenous infusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eribulin mesilate (substance) Inferred relationship Some
Eribulin mesylate 0.5mg/mL conventional release solution for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eribulin mesilate (substance) Inferred relationship Some
Product containing precisely eribulin (as eribulin mesilate) 440 microgram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eribulin mesilate (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start